BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

404 related articles for article (PubMed ID: 27404032)

  • 1. An assessment of the safety and efficacy of a fractional CO2 laser system for the treatment of vulvovaginal atrophy.
    Sokol ER; Karram MM
    Menopause; 2016 Oct; 23(10):1102-7. PubMed ID: 27404032
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of a novel fractional CO2 laser for the treatment of genitourinary syndrome of menopause: 1-year outcomes.
    Sokol ER; Karram MM
    Menopause; 2017 Jul; 24(7):810-814. PubMed ID: 28169913
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A 12-week treatment with fractional CO2 laser for vulvovaginal atrophy: a pilot study.
    Salvatore S; Nappi RE; Zerbinati N; Calligaro A; Ferrero S; Origoni M; Candiani M; Leone Roberti Maggiore U
    Climacteric; 2014 Aug; 17(4):363-9. PubMed ID: 24605832
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Technological evolution in the radiofrequency treatment of vaginal laxity and menopausal vulvo-vaginal atrophy and other genitourinary symptoms: first experiences with a novel dynamic quadripolar device.
    Vicariotto F; Raichi M
    Minerva Ginecol; 2016 Jun; 68(3):225-36. PubMed ID: 27206062
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sexual function after fractional microablative CO₂ laser in women with vulvovaginal atrophy.
    Salvatore S; Nappi RE; Parma M; Chionna R; Lagona F; Zerbinati N; Ferrero S; Origoni M; Candiani M; Leone Roberti Maggiore U
    Climacteric; 2015 Apr; 18(2):219-25. PubMed ID: 25333211
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dynamic quadripolar radiofrequency treatment of vaginal laxity/menopausal vulvo-vaginal atrophy: 12-month efficacy and safety.
    Vicariotto F; DE Seta F; Faoro V; Raichi M
    Minerva Ginecol; 2017 Aug; 69(4):342-349. PubMed ID: 28608667
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of fractional CO2 laser treatment in postmenopausal women with genitourinary syndrome: a multicenter study.
    Filippini M; Luvero D; Salvatore S; Pieralli A; Montera R; Plotti F; Candiani M; Angioli R
    Menopause; 2020 Jan; 27(1):43-49. PubMed ID: 31794500
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized clinical trial comparing vaginal laser therapy to vaginal estrogen therapy in women with genitourinary syndrome of menopause: The VeLVET Trial.
    Paraiso MFR; Ferrando CA; Sokol ER; Rardin CR; Matthews CA; Karram MM; Iglesia CB
    Menopause; 2020 Jan; 27(1):50-56. PubMed ID: 31574047
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vulvo-vaginal atrophy: a new treatment modality using thermo-ablative fractional CO2 laser.
    Perino A; Calligaro A; Forlani F; Tiberio C; Cucinella G; Svelato A; Saitta S; Calagna G
    Maturitas; 2015 Mar; 80(3):296-301. PubMed ID: 25596815
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fractional CO
    Lang P; Dell JR; Rosen L; Weiss P; Karram M
    Lasers Surg Med; 2017 Dec; 49(10):882-885. PubMed ID: 28881431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fractional CO
    Siliquini GP; Tuninetti V; Bounous VE; Bert F; Biglia N
    Climacteric; 2017 Aug; 20(4):379-384. PubMed ID: 28503946
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety evaluation of fractional CO
    Di Donato V; D'Oria O; Scudo M; Prata G; Fischetti M; Lecce F; Schiavi MC; Giannini A; Muzii L; Battaglia F; Monti M; Benedetti Panici P
    Maturitas; 2020 May; 135():34-39. PubMed ID: 32252962
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [How I do? a treatment with fractional CO
    Jardin I; Louis-Vahdat C; Canlorbe G; Mergui JL; Uzan C; Azaïs H
    Gynecol Obstet Fertil Senol; 2018 Nov; 46(10-11):735-739. PubMed ID: 30266539
    [No Abstract]   [Full Text] [Related]  

  • 14. Rationale and design for fractional microablative CO
    Flint R; Cardozo L; Grigoriadis T; Rantell A; Pitsouni E; Athanasiou S
    Climacteric; 2019 Jun; 22(3):307-311. PubMed ID: 30676818
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Short-Term Efficacy and Safety of Non-Ablative Laser Treatment Alone or with Estriol or Moisturizers in Postmenopausal Women with Vulvovaginal Atrophy.
    Alvisi S; Lami A; Baldassarre M; Lenzi J; Mancini I; Seracchioli R; Meriggiola MC
    J Sex Med; 2022 May; 19(5):761-770. PubMed ID: 35370104
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Fractional CO
    Li J; Li H; Zhou Y; Xie M; Miao Y; Wang L; Zhao Y; Ying T; Hu Y; Chen Y; Chen Y; Sun X; Wang J
    Lasers Surg Med; 2021 Jul; 53(5):647-653. PubMed ID: 33211334
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vaginal CO
    Pearson A; Booker A; Tio M; Marx G
    Breast Cancer Res Treat; 2019 Nov; 178(1):135-140. PubMed ID: 31377895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Short-term efficacy of vaginal CO
    Kozma B; Póka R; Sipos A; Ács N; Takács P
    Orv Hetil; 2019 Oct; 160(41):1617-1622. PubMed ID: 31587579
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment to External Labia and Vaginal Canal With CO2 Laser for Symptoms of Vulvovaginal Atrophy in Postmenopausal Women.
    Samuels JB; Garcia MA
    Aesthet Surg J; 2019 Jan; 39(1):83-93. PubMed ID: 29726916
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fractional CO2 laser for vulvovaginal atrophy (VVA) dyspareunia relief in breast cancer survivors.
    Pieralli A; Fallani MG; Becorpi A; Bianchi C; Corioni S; Longinotti M; Tredici Z; Guaschino S
    Arch Gynecol Obstet; 2016 Oct; 294(4):841-6. PubMed ID: 27170261
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.